Endocrine disruptor chemicals, adipokines and reproductive functions Patrycja KurowskaEwa MlyczyńskaAgnieszka Rak Review 27 April 2022 Pages: 205 - 218
Iodine as a potential endocrine disruptor—a role of oxidative stress Małgorzata Karbownik-LewińskaJan StępniakAndrzej Lewiński Review Open access 20 June 2022 Pages: 219 - 240
Influence of COVID-19 vaccines on endocrine system Ying ZhaoXiaohong Wu Mini Review 25 June 2022 Pages: 241 - 246
The osteo-metabolic phenotype of COVID-19: an update Luigi di FilippoStefano FraraAndrea Giustina Mini Review 20 July 2022 Pages: 247 - 254
Radioligand therapy (RLT) as neoadjuvant treatment for inoperable pancreatic neuroendocrine tumors: a literature review Luca UrsoAlberto NieriMirco Bartolomei Mini Review Open access 26 August 2022 Pages: 255 - 261
Ultrasound and FibroScan® Controlled Attenuation Parameter in patients with MAFLD: head to head comparison in assessing liver steatosis Andrea SalmiLuigi di FilippoAndrea Giustina Original Article 18 August 2022 Pages: 262 - 269
Transcriptome analysis of peripheral blood mononuclear cells in patients with type 1 diabetes mellitus Zhaoxiang WangLi ZhangGuoyue Yuan Original Article 17 August 2022 Pages: 270 - 279
Type 2 diabetes in children and adolescents: distinct characteristics and evidence-based management Kyriaki KaravanakiStavroula A. PaschouAlexandra Soldatou Review 27 August 2022 Pages: 280 - 295
Tumor mutation burden-assisted risk stratification for papillary thyroid cancer Zhijiang ChenWeiran WangHaixia Guan Original Article 12 August 2022 Pages: 296 - 305
Identification of two potential immune-related biomarkers of Graves’ disease based on integrated bioinformatics analyses Yihan ZhangJia WeiHuanbai Xu Original Article 13 August 2022 Pages: 306 - 314
Comparison between total thyroidectomy and hemithyroidectomy in TIR3B thyroid nodules management Domenico AlbanoGiorgio TregliaClaudio Casella Original Article Open access 20 August 2022 Pages: 315 - 320
The combination of T2-mapping value of lacrimal gland and clinical indicators can improve the stage prediction of Graves’ ophthalmopathy compared to clinical activity scores Mengda JiangXuefei SongYinwei Li Original Article 23 August 2022 Pages: 321 - 328
Global changes in chromatin accessibility and transcription in growth hormone-secreting pituitary adenoma Meng WangChenxing JiZhao Ye Original Article Open access 10 August 2022 Pages: 329 - 342
Partial response to first generation SSA guides the choice and predict the outcome of second line therapy in acromegaly Sabrina ChiloiroDenise CostaLaura De Marinis Original Article Open access 20 August 2022 Pages: 343 - 353
Impact of surgical factors on delayed hyponatremia in patients with nonfunctioning pituitary adenoma after endonasal endoscopic transsphenoidal procedure Haku TanakaFumihiko NishimuraHiroyuki Nakase Original Article Open access 19 August 2022 Pages: 354 - 362
Adrenal venous sampling in primary aldosteronism: Experience of a Spanish multicentric study (Results from the SPAIN-ALDO Register) Marta Araujo-CastroMiguel Paja FanoFelicia A. Hanzu Original Article 25 June 2022 Pages: 363 - 372
COVID-19 patients with altered steroid hormone levels are more likely to have higher disease severity Sevilay SezerCeylan BalGülsen Yılmaz Original Article 30 July 2022 Pages: 373 - 379
Bone metastases in midgut neuroendocrine tumors: imaging characteristics, distribution, and risk factors Maxime LelièvreElizabeth Katherine Anna TriumbariDavid Morland Original Article 07 October 2022 Pages: 380 - 386
The COVID-19 outbreak and de-escalation of thyroid cancer diagnosis and treatment Giorgio GraniLaura CiottiCosimo Durante Brief report 08 July 2022 Pages: 387 - 391
Diabetes technology and cybersecurity—a growing cause for concern Henrique Carmona AlexandrinoMarta Almeida FerreiraMaria João Oliveira Letter to the Editor 09 September 2022 Pages: 392 - 393
